Along with these observations, the PI3K inhibitor BEZ235 together with the AR antagonist Enzalutamide resulted in an enhanced apoptosis rate in a PTEN negative PCa [121]. The gene discussed is PIK3CA; the disease is posterior cortical atrophy.